Fyr Diagnostics INC
UEI FXC2KX47NS48 · MT · SAM.gov record ↗
$355K
FY2025 obligations
1
Contract awards
Sep 14, 2025
First action
Sep 9, 2025
Latest action
Obligations by agency
- Department Of Health And Human Services$355K
Obligations by NAICS
Monthly obligations
Sep 25
Contracts ending within 18 months (recompete watch)
- 75N91025C00044 ↗$355K
TUMOR-DERIVED EXTRACELLULAR VESICLES FOR DIAGNOSIS OF EARLY-STAGE OVARIAN CANCER
- Ends
- Sep 13, 2026
- Started
- Sep 14, 2025
- Agency
- National Institutes Of Health
- NAICS
- 541714
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N91025C00044 ↗ | TUMOR-DERIVED EXTRACELLULAR VESICLES FOR DIAGNOSIS OF EARLY-STAGE OVARIAN CANCER | National Institutes Of Health | 541714 | $355K | Sep 14, 2025 | Sep 13, 2026 |
Largest awards
- 75N91025C00044 ↗$355K
TUMOR-DERIVED EXTRACELLULAR VESICLES FOR DIAGNOSIS OF EARLY-STAGE OVARIAN CANCER
- Ends
- Sep 13, 2026
- Started
- Sep 14, 2025
- Agency
- National Institutes Of Health
- NAICS
- 541714
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N91025C00044 ↗ | TUMOR-DERIVED EXTRACELLULAR VESICLES FOR DIAGNOSIS OF EARLY-STAGE OVARIAN CANCER | National Institutes Of Health | 541714 | $355K | Sep 14, 2025 | Sep 13, 2026 |